These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20152041)

  • 21. Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.
    Parker M; Haycox A; Graves J
    Pharmacoeconomics; 2011 Aug; 29(8):719-30. PubMed ID: 21635017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.
    Scuffham PA; Whitty JA; Mitchell A; Viney R
    Pharmacoeconomics; 2008; 26(4):297-310. PubMed ID: 18370565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
    Brazier JE; Rowen D; Mavranezouli I; Tsuchiya A; Young T; Yang Y; Barkham M; Ibbotson R
    Health Technol Assess; 2012 Jul; 16(32):1-114. PubMed ID: 22832015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments.
    Kwon J; Smith S; Raghunandan R; Howell M; Huynh E; Kim S; Bentley T; Roberts N; Lancsar E; Howard K; Wong G; Craig J; Petrou S
    Appl Health Econ Health Policy; 2023 Jul; 21(4):559-584. PubMed ID: 37133712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A conceptual map of health-related quality of life dimensions: key lessons for a new instrument.
    Olsen JA; Misajon R
    Qual Life Res; 2020 Mar; 29(3):733-743. PubMed ID: 31676970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A qualitative evaluation of the validity of published health utilities and generic health utility measures for capturing health-related quality of life (HRQL) impact of differentiated thyroid cancer (DTC) at different treatment phases.
    Gallop K; Kerr C; Simmons S; McIver B; Cohen EE
    Qual Life Res; 2015 Feb; 24(2):325-38. PubMed ID: 25106505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating health state utilities in primary hyperoxaluria type 1: a valuation study.
    de Freitas HM; Danese D; Hubig L; Lloyd A; Lombardelli S
    J Med Econ; 2023; 26(1):386-393. PubMed ID: 36852648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas.
    Richardson J; Iezzi A; Khan MA; Chen G; Maxwell A
    Med Decis Making; 2016 Feb; 36(2):147-59. PubMed ID: 26582319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health state valuation in low- and middle-income countries: a systematic review of the literature.
    Kularatna S; Whitty JA; Johnson NW; Scuffham PA
    Value Health; 2013; 16(6):1091-9. PubMed ID: 24041360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M
    Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010.
    Wisløff T; Hagen G; Hamidi V; Movik E; Klemp M; Olsen JA
    Pharmacoeconomics; 2014 Apr; 32(4):367-75. PubMed ID: 24477679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments.
    Hawthorne G; Richardson J; Day NA
    Ann Med; 2001 Jul; 33(5):358-70. PubMed ID: 11491195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping between 6 Multiattribute Utility Instruments.
    Chen G; Khan MA; Iezzi A; Ratcliffe J; Richardson J
    Med Decis Making; 2016 Feb; 36(2):160-75. PubMed ID: 25840901
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.